Shandong Wit Dyne Health Co.,Ltd.

SZSE:000915 Stock Report

Market Cap: CN¥5.6b

Shandong Wit Dyne HealthLtd Future Growth

Future criteria checks 3/6

Shandong Wit Dyne HealthLtd is forecast to grow earnings and revenue by 14.3% and 13.8% per annum respectively. EPS is expected to grow by 14.3% per annum. Return on equity is forecast to be 22.9% in 3 years.

Key information

14.3%

Earnings growth rate

14.3%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate13.8%
Future return on equity22.9%
Analyst coverage

Low

Last updated19 Aug 2024

Recent future growth updates

No updates

Recent updates

There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

Sep 14
There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

May 12
Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

Apr 24
Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

Earnings and Revenue Growth Forecasts

SZSE:000915 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,556862N/A1,6171
12/31/20253,169763N/A1,4421
12/31/20242,809671N/A1,2611
6/30/20242,4855959501,000N/A
3/31/20242,4955901,0191,069N/A
12/31/20232,4845851,1241,175N/A
9/30/20232,2415251,1581,209N/A
6/30/20232,2695441,1081,184N/A
3/31/20232,2975351,1691,256N/A
12/31/20222,3415271,1071,196N/A
9/30/20222,2735249961,093N/A
6/30/20222,2414569081,023N/A
3/31/20222,143427785895N/A
1/1/20222,027380636756N/A
9/30/20212,027382693799N/A
6/30/20212,000385676753N/A
3/31/20211,986350692777N/A
12/31/20201,821291634736N/A
9/30/20201,852277564692N/A
6/30/20201,821250501643N/A
3/31/20201,804230257415N/A
12/31/20191,80020471244N/A
9/30/20191,56214139223N/A
6/30/20191,54113717200N/A
3/31/20191,39080214371N/A
1/1/20191,526130407539N/A
9/30/20181,699170376571N/A
6/30/20181,698178416596N/A
3/31/20181,775231N/A509N/A
12/31/20171,767243N/A426N/A
9/30/20171,794255N/A410N/A
6/30/20171,694239N/A422N/A
3/31/20171,662238N/A450N/A
12/31/20161,545198N/A501N/A
9/30/20161,529229N/A474N/A
6/30/20161,415195N/A345N/A
3/31/20161,312156N/A341N/A
12/31/20151,233152N/A290N/A
9/30/20151,246162N/A227N/A
6/30/20151,310206N/A287N/A
3/31/20151,317211N/A236N/A
12/31/20141,374217N/A272N/A
9/30/20141,266178N/A255N/A
6/30/20141,198149N/A230N/A
3/31/20141,173165N/A222N/A
12/31/20131,095153N/A216N/A
9/30/20131,011152N/A190N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000915's forecast earnings growth (14.3% per year) is above the savings rate (2.9%).

Earnings vs Market: 000915's earnings (14.3% per year) are forecast to grow slower than the CN market (23.2% per year).

High Growth Earnings: 000915's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000915's revenue (13.8% per year) is forecast to grow faster than the CN market (13.3% per year).

High Growth Revenue: 000915's revenue (13.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000915's Return on Equity is forecast to be high in 3 years time (22.9%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y